The Optispan Podcast with Matt Kaeberlein cover image

Longevity Scientist Reacts to Bryan Johnson's "I Edited My DNA To Live Forever" |50-Longevity Reacts

The Optispan Podcast with Matt Kaeberlein

00:00

Challenges in Regulatory Approval and Scalability of Longevity Therapies

The chapter explores the high costs and regulatory hurdles in bringing longevity therapies to market, drawing comparisons with mRNA vaccine technology. It also discusses the potential of mRNA technology for targeting aging processes and introduces a new gene therapy technology with a built-in safety mechanism.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app